These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35073712)

  • 1. Effectiveness of different coils for endovascular coiling for intractable hepatic encephalopathy caused by a portosystemic shunt.
    Ishikawa T; Imai M; Endo S; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T; Yoshida T
    Ann Palliat Med; 2022 Jun; 11(6):1954-1960. PubMed ID: 35073712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices.
    Kim SK; Lee KA; Sauk S; Korenblat K
    Korean J Radiol; 2017; 18(2):345-354. PubMed ID: 28246514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon-occluded antegrade transvenous obliteration with or without balloon-occluded retrograde transvenous obliteration for the management of gastric varices: concept and technical applications.
    Saad WE; Kitanosono T; Koizumi J
    Tech Vasc Interv Radiol; 2012 Sep; 15(3):203-25. PubMed ID: 23021832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices.
    Arai H; Abe T; Takagi H; Mori M
    World J Gastroenterol; 2006 Jun; 12(24):3866-73. PubMed ID: 16804972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A; Chalamarla LK; Singla N; Shasthry SM; Sarin SK
    Eur Radiol; 2020 Jun; 30(6):3462-3472. PubMed ID: 32048037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon-Occluded Retrograde Transvenous Obliteration versus Transjugular Intrahepatic Portosystemic Shunt for the Management of Gastric Variceal Bleeding.
    Gimm G; Chang Y; Kim HC; Shin A; Cho EJ; Lee JH; Yu SJ; Yoon JH; Kim YJ
    Gut Liver; 2018 Nov; 12(6):704-713. PubMed ID: 29938456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications.
    Saad WE; Kitanosono T; Koizumi J; Hirota S
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):101-51. PubMed ID: 23830671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transhepatic obliteration of a large portosystemic shunt associated with hepatic encephalopathy using a technique of n-butyl-2-cyanoacrylate injection inside hydrogel-coated coils: A case report.
    Nozawa Y; Masuda K; Katayama T; Kobashi Y; Ikeda K; Suzuki T; Fukuda T
    Radiol Case Rep; 2022 Dec; 17(12):4738-4741. PubMed ID: 36212760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Versus Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Treatment of Gastric Varices Because of Portal Hypertension: A Systematic Review and Meta-Analysis.
    Paleti S; Nutalapati V; Fathallah J; Jeepalyam S; Rustagi T
    J Clin Gastroenterol; 2020 Aug; 54(7):655-660. PubMed ID: 31688366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
    Wang YB; Zhang JY; Gong JP; Zhang F; Zhao Y
    J Gastroenterol Hepatol; 2016 Apr; 31(4):727-33. PubMed ID: 26637789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Balloon-, Plug- and Coil-assisted Retrograde Transvenous Obliteration of Multiple Portosystemic Shunts to Treat Recurrent Hepatic Encephalopathy: A Case Report.
    Anandpara KM; Mukund A; Sarin SK
    J Clin Exp Hepatol; 2020; 10(4):402-406. PubMed ID: 32655241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration.
    Sabri SS; Abi-Jaoudeh N; Swee W; Saad WE; Turba UC; Caldwell SH; Angle JF; Matsumoto AH
    J Vasc Interv Radiol; 2014 Mar; 25(3):355-61. PubMed ID: 24468043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques.
    Saad WE; Nicholson DB
    Tech Vasc Interv Radiol; 2013 Jun; 16(2):152-7. PubMed ID: 23830672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous use of plug-assisted and coil-assisted retrograde transvenous obliteration for treating refractory hepatic encephalopathy in a patient with two portosystemic shunts: A case report.
    Ju SG; Lee JM; Shim J
    Medicine (Baltimore); 2023 Jun; 102(22):e33961. PubMed ID: 37266629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of portal-systemic encephalopathy caused by multiple portosystemic shunts successfully treated with percutaneous transhepatic obliteration.
    Watanabe Y; Osaki A; Yamazaki S; Yamazaki H; Kimura K; Takaku K; Sato M; Waguri N; Terai S
    Clin J Gastroenterol; 2022 Oct; 15(5):968-974. PubMed ID: 35821556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon-occluded retrograde transvenous obliteration for treatment of portal hypertensive related varices.
    Stoleru G; Henry Z
    Curr Opin Gastroenterol; 2023 May; 39(3):140-145. PubMed ID: 36976877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts.
    Mukund A; Deogaonkar G; Rajesh S; Shasthry SM; Sarin SK
    Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1010-1016. PubMed ID: 28180928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.